课题基金 / 基金详情

The clinical significance of sex hormone crosstalk in estrogen receptor positive breast cancer.

The clinical significance of sex hormone crosstalk in estrogen receptor positive breast cancer.
雌激素受体阳性乳腺癌中性激素串扰的临床意义。
批准号:
nhmrc : 1130077
负责人:
A/Pr Elgene Lim
金额:
$68.95万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2020-12-31

项目摘要

项目成果

A/Pr Elgene Lim的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer is mainly a disease in which the sex hormone estrogen stimulates uncontrolled growth. We have recently discovered that other sex hormones, including progesterone and androgen, can redirect the actions of estrogen in breast cancers to halt growth or make a tumour disappear. This study will examine the complex interaction between all three sex hormones to develop new, more effective strategies for treating breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pushing AR toward better outcomes in breast and prostate cancers
  • 批准号:
    nhmrc : 1145777
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.53万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : GNT1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $117.12万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : 1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $79.19万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic
  • 批准号:
    nhmrc : GNT1153049
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $249.64万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
海外基金